Minerva Neurosciences Inc (NERV) has fallen Monday morning, with the stock decreasing -4.94% in pre-market trading to 2.5. NERV's short-term technical score of 8 indicates that the stock has traded less bullishly over the last month than 92% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, the stock ranks higher than 12% of stocks. Minerva Neurosciences Inc has fallen 72.14% over the past month, closing at $10.79 on February 5. During this period of time, the stock fell as low as $2.63 and as high as $13.49. NERV has an average analyst recommendation of Sell. The company has an average price target of $11.00.
NERV has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on NERV!